Why is Rossari Biotech falling/rising?

As of 15-Jul, Rossari Biotech Ltd is experiencing a price increase, currently at Rs 742.75, reflecting a rise of Rs 43.05 or 6.15%. The stock has shown strong performance today, outperforming its sector by 5.1% and reaching an intraday high of Rs 767.55, which is a 9.7% increase. Over the past week, the stock has gained 9.11%, while its one-month return stands at 9.41%. Despite a year-to-date decline of 5.71% and a one-year drop of 9.77%, the company has seen a 4.4% rise in profits, contributing to its attractive valuation with a Price to Book Value of 3.5. The stock is trading at a discount compared to its peers, and high institutional holdings at 21.32% suggest confidence in the company's fundamentals.
In the broader market context, the Sensex has declined by 1.36% over the past week, contrasting with Rossari Biotech's positive performance. This indicates that the stock is not only rising in isolation but is also gaining traction against a backdrop of broader market weakness. While the stock's liquidity remains adequate for trading, there has been a notable decrease in delivery volume, which fell by 18.47% against the five-day average. This could suggest a potential concern regarding investor participation, despite the stock's current upward trajectory.